A benzoylphenylurea-based stabilizer of TERT G-quadruplex DNA for prostate cancer

DISEASE CATEGORY: Cancer

INDICATION: Prostate cancer

A team including Reglagene LLC co-founder Laurence Hurley identified a benzoylphenylurea-based stabilizer of

Read the full 175 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE